Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Knowledge and perception of biosimilars in ambulatory care: a survey among Belgian community pharmacists and physicians
Liese Barbier, Yannick Vandenplas, Steven Simoens, et al.
Journal of Pharmaceutical Policy and Practice (2021) Vol. 14, Iss. 1
Open Access | Times Cited: 13

Showing 13 citing articles:

Regulatory Information and Guidance on Biosimilars and Their Use Across Europe: A Call for Strengthened One Voice Messaging
Liese Barbier, Allary Mbuaki, Steven Simoens, et al.
Frontiers in Medicine (2022) Vol. 9
Open Access | Times Cited: 27
An international comparative analysis and roadmap to sustainable biosimilar markets
Khalid A. Alnaqbi, Agnès Bellanger, Alex Brill, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 14
Understanding Community Pharmacists’ Knowledge, Attitudes, and Practices Regarding Biosimilar Drugs: A Cross‐Sectional Survey
Anan S. Jarab, Walid Al‐Qerem, Karem H. Alzoubi, et al.
International Journal of Clinical Practice (2025) Vol. 2025, Iss. 1
Open Access
Awareness and Knowledge of Biosimilars Among Rheumatologists and Patients
Muhammad Shiraz Niaz, S M Syed Mohamed Suhail, Usama Mahmood
Journal of Health and Rehabilitation Research (2025) Vol. 5, Iss. 1, pp. 1-7
Closed Access
Barriers and Enablers Affecting the Uptake of Biosimilar Medicines Viewed Through the Lens of Actor Network Theory: A Systematic Review
C. Rieger, Judith Dean, Lisa Hall, et al.
BioDrugs (2024) Vol. 38, Iss. 4, pp. 541-555
Open Access | Times Cited: 3
Perceptions About Biosimilar Medicines Among Belgian Patients in the Ambulatory Care
Yannick Vandenplas, Liese Barbier, Steven Simoens, et al.
Frontiers in Pharmacology (2022) Vol. 12
Open Access | Times Cited: 13
Pharmacists’ Perspectives of Biosimilars: A Systematic Review
Noraisyah Mohd Sani, Zoriah Aziz, Rema Panickar, et al.
BioDrugs (2022) Vol. 36, Iss. 4, pp. 489-508
Closed Access | Times Cited: 9
Understanding US Physician and Pharmacist Attitudes Toward Biosimilar Products: A Qualitative Study
Douglas J. Rupert, Alyssa Jordan, Marina A. Ziemian, et al.
BioDrugs (2022) Vol. 36, Iss. 5, pp. 645-655
Closed Access | Times Cited: 5
Pharmacists’ knowledge, familiarity, and attitudes towards biosimilar drugs among practicing Jordanian pharmacists: A cross sectional study
Osama H. Abusara, Samar Bishtawi, Walid Al‐Qerem, et al.
Journal of King Saud University - Science (2023) Vol. 35, Iss. 6, pp. 102767-102767
Open Access | Times Cited: 2
Tumor Necrosis Alpha (TNF-α) Antagonists Used in Chronic Inflammatory Rheumatic Diseases: Risks and their Minimization Measures
Rim Lakhmiri, Yahia Cherrah, Samira Serragui
Current Drug Safety (2024) Vol. 19, Iss. 4, pp. 431-443
Closed Access
Mitigating the Nocebo Effect in Biosimilar Use and Switching: A Systematic Review
Elif Car, Yannick Vandenplas, Teresa Barcina Lacosta, et al.
Pharmaceutical Medicine (2024)
Open Access
Pharmacists' confidence in explaining biosimilars to patients before a nationwide medicine change: A cross-sectional study
Chiara Gasteiger, Norina Gasteiger, Keith J. Petrie
Exploratory Research in Clinical and Social Pharmacy (2022) Vol. 8, pp. 100199-100199
Open Access | Times Cited: 2
Regulatory Information and Guidance on Biosimilars and their Use across Europe: A Call for Strengthened One Voice Messaging
Liese Barbier
(2022)
Open Access
Page 1

Scroll to top